chr8-140287691-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000438773.4(TRAPPC9):c.1898C>T(p.Ala633Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00038 in 1,614,170 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A633A) has been classified as Likely benign.
Frequency
Consequence
ENST00000438773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAPPC9 | NM_001160372.4 | c.1898C>T | p.Ala633Val | missense_variant | 13/23 | ENST00000438773.4 | NP_001153844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAPPC9 | ENST00000438773.4 | c.1898C>T | p.Ala633Val | missense_variant | 13/23 | 1 | NM_001160372.4 | ENSP00000405060 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000422 AC: 106AN: 251412Hom.: 0 AF XY: 0.000412 AC XY: 56AN XY: 135898
GnomAD4 exome AF: 0.000382 AC: 558AN: 1461888Hom.: 1 Cov.: 32 AF XY: 0.000375 AC XY: 273AN XY: 727244
GnomAD4 genome AF: 0.000361 AC: 55AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74454
ClinVar
Submissions by phenotype
Intellectual disability, autosomal recessive 13 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 29, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Aug 26, 2022 | This sequence variant is a single nucleotide substitution (C>T) at coding position 1898 of the TRAPPC9 gene that results in an alanine to valine amino acid change at residue 633 of the TRAPPC9 protein. This is a previously reported variant (ClinVar) that has been observed in the literature in a cohort of individuals with severe specific language impairment (PMID: 28440294). This variant is present in healthy population datasets (gnomAD database, 114 of 282816 alleles or 0.04%). Multiple bioinformatic tools predict that this variant would be damaging, and the Ala633 residue is highly conserved across the vertebrate species examined. Functiol studies testing the effect of this variant on protein structure or activity have not been performed, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this to be a variant of uncertain significance. ACMG Criteria: BP1, PP3 - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 01, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 731 of the TRAPPC9 protein (p.Ala731Val). This variant is present in population databases (rs375300224, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with TRAPPC9-related conditions. ClinVar contains an entry for this variant (Variation ID: 212421). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 06, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 08, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at